Traduction de «type 1 reactional state » (Anglais → Français) :

type 1 reaction [ type 1 reactional state | type 1 lepra reaction | lepra type-1 reaction ]

Definition: Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is free-floating ). The dominant symptoms are variable but include complaints of persistent nervousness, trembling, muscular tensions, sweating, lightheadedness, palpitations, dizziness, and epigastric discomfort. Fears that the patient or a relative will shortly become ill or have an accident are often expressed. | Anxiety:neurosis | reaction | state

Definition: A transient disorder that develops in an individual without any other apparent mental disorder in response to exceptional physical and mental stress and that usually subsides within hours or days. Individual vulnerability and coping capacity play a role in the occurrence and severity of acute stress reactions. The symptoms show a typically mixed and changing picture and include an initial state of daze with some constriction of the field of consciousness and narrowing of attention, inability to comprehend stimuli, and diso ...[+++]rientation. This state may be followed either by further withdrawal from the surrounding situation (to the extent of a dissociative stupor - F44.2), or by agitation and over-activity (flight reaction or fugue). Autonomic signs of panic anxiety (tachycardia, sweating, flushing) are commonly present. The symptoms usually appear within minutes of the impact of the stressful stimulus or event, and disappear within two to three days (often within hours). Partial or complete amnesia (F44.0) for the episode may be present. If the symptoms persist, a change in diagnosis should be considered. | Acute:crisis reaction | reaction to stress | Combat fatigue Crisis state Psychic shock

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include sel ...[+++]f-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Since the objectives of this [specify the type of act], (if relevant, specify the objectives) cannot be sufficiently achieved by the Member States [give reasons] but can rather, by reason of [specify the scale or effects of the action], be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty on European Union. In accordance with the prin ...[+++]ciple of proportionality as set out in that Article, this [specify the type of act] does not go beyond what is necessary in order to achieve those objectives.

materials chemistry | solid-state chemistry types | solid materials properties | solid-state chemistry

degradation reaction in the absorbed state

anaphylactic type reaction

nutrition of healthy person | nutrition of people in good state of health | nutrition of healthy persons | type of nutrition of healthy person

Mandatory pooling of resources to enhance the European Border and Coast Guard Agency's rapid reaction capability: To reinforce the manpower of the responsible national border guards,since 7 December, a Rapid Reaction Pool of 1,500 border guards and other officers has been placed at the immediate disposal of the Agency to provide support on the ground for immediate interventions when requested by Member States alongside a Rapid Reaction Equipment Pool consisting of equipment such as vessels and helicopters to carry out rapid border int ...[+++]erventions.

To harmonise the type of information and to keep the work load to a minimum, Member States submit reactions in particular in the following situations:

The Contact Point of the reacting Member State together with the responsible authority ensure that all data provided in a reaction is accurate and complete and that there is no confusion with similar products of the same or similar category or type that are available on the EU market.

Medication errors that result in an adverse reaction should be reported to the competent authorities for medicines: The definition of adverse drug reaction should be clarified to make clear that companies report medication errors that result in an adverse reaction to the competent authorities for medicines and ensure that all the relevant Member State authorities share data (including between the authorities for medicines and any authorities for patient safety).